Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
|Videos|November 14, 2016
Data Analytics in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.
Advertisement
John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.
Advertisement
Related to this article
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Advertisement
Advertisement
Trending on Pharmacy Times
1
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
2
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
5